Market Value984,662,642
Total Holdings57
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NVAX / Novavax, Inc.
SPY / SPDR S&P 500 ETF Put
GMED / Globus Medical, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
RVTY / Revvity, Inc.
IFRX / InflaRx N.V.
GKOS / Glaukos Corporation
PTGX / Protagonist Therapeutics, Inc.
ZIMV / ZimVie Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
IONS / Ionis Pharmaceuticals, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
PDCO / Patterson Companies, Inc.
EOLS / Evolus, Inc.
XENE / Xenon Pharmaceuticals Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
TSVT / 2seventy bio, Inc.
TLT / iShares Trust - iShares 20+ Year Treasury Bond ETF Put
MEDP / Medpace Holdings, Inc.
XRAY / DENTSPLY SIRONA Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
DXCM / DexCom, Inc.
GH / Guardant Health, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
HSIC / Henry Schein, Inc.
DHR / Danaher Corporation
SUPN / Supernus Pharmaceuticals, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
SNDX / Syndax Pharmaceuticals, Inc.
KPTI / Karyopharm Therapeutics Inc.
RGEN / Repligen Corporation
FTRE / Fortrea Holdings Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ACIU / AC Immune SA
AMARIN CORP PLC / SPONS ADR NEW (023111206)
PCVX / Vaxcyte, Inc.
ALEC / Alector, Inc.
STRO / Sutro Biopharma, Inc.
HQY / HealthEquity, Inc.
ALGN / Align Technology, Inc.
ZBIO / Zenas BioPharma, Inc.
HCA / HCA Healthcare, Inc.
GOSS / Gossamer Bio, Inc.
CLDX / Celldex Therapeutics, Inc.
AVTR / Avantor, Inc.
EHTH / eHealth, Inc.
MRUS / Merus N.V.
MOH / Molina Healthcare, Inc.
CNC / Centene Corporation
XOMA / XOMA Royalty Corporation
ABSI / Absci Corporation
VTRS / Viatris Inc.
KPTI / Karyopharm Therapeutics Inc.
MNKD / MannKind Corporation
ITOS / iTeos Therapeutics, Inc.
NTRA / Natera, Inc.
BRKR / Bruker Corporation
VRDN / Viridian Therapeutics, Inc.
TECH / Bio-Techne Corporation
LQDA / Liquidia Corporation
TVTX / Travere Therapeutics, Inc.
ETNB / 89bio, Inc.
ELV / Elevance Health, Inc.
INSP / Inspire Medical Systems, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
VERA / Vera Therapeutics, Inc.
ICLR / ICON Public Limited Company
CYH / Community Health Systems, Inc.
HUM / Humana Inc.
PBYI / Puma Biotechnology, Inc.
UTHR / United Therapeutics Corporation
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
BCRX / BioCryst Pharmaceuticals, Inc.
EW / Edwards Lifesciences Corporation
TFX / Teleflex Incorporated
NBIX / Neurocrine Biosciences, Inc.
QQQ / Invesco QQQ Trust, Series 1